CAS 326866-17-5

4-PiperidinecarboxaMide, N-[4-(6-Methyl-2-benzothiazolyl)phenyl]-1-(2-thienylsulfonyl)-

CAS : 326866-17-5

Formule : C₂₄H₂₃N₃O₃S₃

Degré de pureté : 95%

Couleur et forme : Solid

Masse moléculaire : 497.6527

Ref: IN-DA00C6FI

FAAH inhibitor 1

CAS : 326866-17-5

FAAH inhibitor 1

Degré de pureté : ≥98%

Masse moléculaire : 497.65g/mol

Ref: 54-BUP12755

FAAH inhibitor 1

CAS : 326866-17-5

FAAH inhibitor 1 is a drug that inhibits the function of fatty acid amide hydrolase (FAAH), an enzyme that breaks down the endocannabinoid anandamide. It is used to treat inflammation, which is caused by pro-inflammatory substances such as cytokines, chemokines, and prostaglandins. FAAH inhibitor 1 is being investigated for its ability to inhibit multidrug resistance in cancer cells. This drug has also been shown to reduce neutrophil recruitment and inflammation in the target tissue. In addition, this drug has been shown to be effective against cyclosporin-resistant neutrophils by inhibiting the function of multidrug resistance protein.

Formule : C₂₄H₂₃N₃O₃S₃

Degré de pureté : Min. 95%

Masse moléculaire : 497.7 g/mol

Ref: 3D-BNA86617

FAAH inhibitor 1

CAS : 326866-17-5

FAAH inhibitor 1 (Benzothiazole analog 3) is an effective FAAH inhibitor with an IC50 of 18 nM.

Formule : C₂₄H₂₃N₃O₃S₃

Degré de pureté : 99.6%

Couleur et forme : Solid

Masse moléculaire : 497.65

Ref: TM-T11256